The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...
In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.
The FDA has granted fast track designation to DYNE-101, a therapy for myotonic dystrophy type 1 (DM1) now in testing in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback